TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | -7 | -9 | -47 | -49 | -68 | -36 |
| P | %wins | 100 | 0 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/21/06 21:05 | 3/17/06 | AVII | Avi Biopharma Inc | OR | Health | Drug | Pharmaceutical Preparations | Bowman Jack L | OR | D | P.d | 32 | 6.36 | 14 | 5 | New | 5 | D | 111 | 160 | 199 | 81 | -20 | -11 | 13 | -2 | 0 | -7 | -9 | -47 | -49 | -68 | |
8/8/03 12:21 | 8/7/03 | NERX | Neorx Corp | WA | Health | Diagn | In Vitro & In Vivo Diagnostic | Bowman Jack L | WA | D | P | 25 | 2.47 | 0 | 10 | 87 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |